Herschler Building East 2nd Floor
122 W 25th St, Cheyenne, WY 82002
Phone: 307-634-9636 bop@wyo.gov
Embedded Files
Mission Statement
The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.Mission Statement
Current News & Information
Current News & Information
The Wyoming State Board of Pharmacy office is moving.
The Wyoming State Board of Pharmacy office is moving.
The Board office is moving to:
Herschler Building East 2nd Floor
122 W 25th St, Cheyenne, WY 82002
The Board's fax line will be temporarily unavailable. Please scan and email any required notification to bop@wyo.gov. You may also mail the original to the Board's new address. Board staff may be contacted by calling 307-634-9636 or by emailing bop@wyo.gov. Responses may be delayed during the move to the new location.
Unfortunately, applications cannot be hand-delivered at this time and must be mailed.
Applications are being updated with the new address. If you choose to use a courier/delivery service other than the United States Postal Service, please ensure that you use the new address.
This meeting was conducted entirely by teleconference
Rules Revisions Signed By Governor
Rules Revisions Signed By Governor
The revisions to the Wyoming Pharmacy Act Rules Chapters 8, 13, 17, 18, and 22 were approved by Governor Gordon on August 19, 2025. The updated chapters are posted on the Wyoming State Board of Pharmacy's website. They can also be accessed on the Wyoming Secretary of State's Wyoming Administrative Rules website at https://rules.wyo.gov/.
Business licenses (resident pharmacies, nonresident pharmacies, wholesale distributors, etc.), business-controlled substance registrations, and individual controlled substance registrant renewals are now open. Click below to learn more and renew your license.
CLOSED Individual controlled substance registrants (MD, DO, PA, APRN, DDS, DVM, etc.) may click here to learn how to renew their CSR during the grace period.
CLOSED Resident pharmacies (resident retail and resident institutional)
CLOSED Nonresident pharmacies
CLOSED Wholesale distributors of prescription drugs for human use, veterinary use, or medical oxygen
CLOSED Outsourcing Facilities
CLOSED Third-party logistics providers
2025-2026 License Renewals for Pharmacy Interns & Methamphetamine Precursor Registration for Manufacturers, Distributors, Retailers are now OPEN.
2025-2026 License Renewals for Pharmacy Interns & Methamphetamine Precursor Registration for Manufacturers, Distributors, Retailers are now OPEN.
Renewal applications must be mailed to the Board office. Faxed or emailed applications are not accepted. Incomplete applications will be returned to the applicant. Renewal fees may be paid through a check, cashier’s check, or money order made payable to the Wyoming State Board of Pharmacy. Pharmacy interns and Methamphetamine Precursor Manufacturer, Distributor, or Retailer Registrants may click below to learn more about renewing their license:
Pharmacy Intern License Renewals
An active license is required to practice in Wyoming. Renewal applications must be mailed to the Board office. Faxed or emailed applications are not accepted. Incomplete applications will be returned to the applicant. Renewal fees may be paid through a check, cashier’s check, or money order made payable to the Wyoming State Board of Pharmacy.Pharmacy interns who attend a college or school of pharmacy other than the University of Wyoming School of Pharmacy must provide verification from their college or school of pharmacy that they are enrolled and currently in good standing with their program.
Pharmacy intern licenses cannot be renewed beyond twenty-four (24) months from the date of graduation from an ACPE-accredited college or school of pharmacy where the initial degree in pharmacy was obtained.
Methamphetamine Precursor Manufacturer, Distributor, or Retailer Registration Renewals
Entities that ship methamphetamine precursor drugs into Wyoming or retailers that sell methamphetamine precursor drugs to individuals in Wyoming must obtain and renew a Methamphetamine Precursor Manufacturer, Distributor, or Retailer Registration.
A Wholesale Distributor that is licensed to ship prescription drugs into Wyoming is not required to hold this license in addition.
Alerts & Other Information
Alerts & Other Information
Twelfth PREP Act Declaration extends
COVID-19 Countermeasures through
December 2029
Twelfth PREP Act Declaration extends
COVID-19 Countermeasures through
December 2029
PREP Act immunity from liability was extended by HHS through through the final day of the applicable Declaration of Emergency, or December 2029 to pharmacists, pharmacy interns, and pharmacy technicians to administer COVID-19 and seasonal influenza vaccines (to those individuals three and over, consistent with other requirements), and COVID-19 tests, regardless of any USG agreement or emergency declaration. For additional information:
REMINDER ALERT
REMINDER ALERT
Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert
Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert
The Board's September 2022 newsletter had an article on the Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition's fraud alert that outlines some new methodologies that are being used to divert both small and large drug shipments. These schemes may involve the impersonation of regulatory personnel, including individuals from state boards of pharmacy and departments of health. They may also involve the impersonation of pharmacy or distributor staff.
Last week a pharmacy in Casper reported being contacted by a scammer posing as the Wyoming Board of Pharmacy, who tried to obtain their wholesale distributor account number. In 2022, a pharmacy in Rock Springs, WY, reported being contacted by a scammer posing as their distributor, who said that they had shipped product to the pharmacy in error and requested that the shipment be returned.
More information is available from the National Association of Boards of Pharmacy®. If you experience an attempt at this type of scam, please email cforsaith@hda.org so that it can be shared with law enforcement.
ALERT Phishing Scam
ALERT Phishing Scam
The Board office has received reports that pharmacists are receiving calls that appear to come from the Board office’s main phone number and that the caller identifies himself or herself as an agent with the Board. The caller is able to confirm some of the pharmacist’s information, such as license number, National Provider Identifier number, and place of employment.
In some cases, the caller accuses the pharmacist of having committed a violation, that his or her license may be suspended or revoked, and that the pharmacist will be arrested if he or she does not answer the caller’s questions. In some cases, the caller alleges that the pharmacist was involved in prescription drug trafficking. Some pharmacists have reported that the caller becomes aggressive and demanding, threatening to have the Federal Bureau of Investigation come and arrest the pharmacist if he or she does not comply.
The Wyoming State Board of Pharmacy will not contact or interact with you in this manner.
The Federal Trade Commission has useful consumer information on how to recognize and avoid phishing scams available at https://www.consumer.ftc.gov/articles/how-recognize-and-avoid-phishing-scams. If you receive such a phone call, please call and report it to the Federal Communications Commission at 888/225- 5322.
DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists
DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists
The Drug Enforcement Administration (DEA) issued a critical alert to healthcare professionals, warning of recent scam calls targeting doctors and pharmacists. Fraudsters are impersonating DEA agents to steal sensitive information and possibly extort money.
DEA personnel will never contact medical practitioners or members of the public by telephone to request personal or sensitive information, demand money or any other form of payment. Legitimate DEA agents will only notify individuals of investigations or legal actions in person or via official letter.
Reported scam tactics continually change but often share many of the same characteristics. Callers use names found online of well-known DEA officials, retired or former Special Agents, and/or police officers in local departments. Callers will also provide fake badge numbers. Additionally, they may:
use an urgent and aggressive tone.
threaten arrest, prosecution, imprisonment, and, in the case of medical practitioners and pharmacists, revocation of their DEA registration.
reference National Provider Identifier numbers and/or state license numbers when calling a medical practitioner. They also may claim that patients are making accusations against the practitioner.
ask for personal information, such as social security number or date of birth.
Protecting Against Identity Theft
The best deterrence against these bad actors is awareness and caution. Anyone receiving a call from a person claiming to be with DEA should report the incident to the FBI at www.ic3.gov. The Federal Trade Commission provides recovery steps, shares information with more than 3,000 law enforcement agencies and takes reports at reportfraud.ftc.gov.
Reporting these scam calls will help federal authorities find, arrest, and stop the criminals engaged in this fraud. Impersonating a federal agent is a violation of federal law, punishable by up to three years in prison; aggravated identity theft carries a mandatory minimum sentence of two years in prison plus fines and restitution.
The DEA is committed to protecting healthcare professionals from these fraudulent schemes. By raising awareness and encouraging prompt reporting, we can help to stop these criminals and ensure the safety and security of our nation's healthcare workforce.
ALERT Fraudulent Prescription SCAM
ALERT Fraudulent Prescription SCAM
The Board has received alerts from pharmacies that an individual or group of individuals are calling in prescriptions for Azithromycin, Ibuprofen, and Promethazine with Codeine. Most of the calls have allegedly come from practitioners in Washington. In some instances, they are asking for particular manufacturers of Promethazine with Codeine, attempting to call multiple sets of prescriptions in at one time, and have requested the pharmacy to ship into another state. The Board urges pharmacists to be cautious and to utilize their professional judgment when exercising their corresponding responsibility and to carefully evaluate such prescriptions for validity before dispensing.
Report abuse